|
|
||||||||
ORIGINAL CONTRIBUTION |
Department of Cardiac Anesthesia
1 Department of Cardiac Surgery, Cardiothoracic Center, All India Institute of Medical Sciences, New Delhi, India
For reprint information contact: Sandeep Chauhan, MD Tel: 91 11 2610 8115 Fax: 91 11 2658 8641 Email: sdeep61{at}yahoo.com Cardiac Anesthesia, Cardiothoracic Centre, All-India Institute of Medical Sciences, New Delhi 110029, India.
To compare different doses of tranexamic acid, 150 consecutive children with congenital cyanotic heart disease were randomly assigned to one of 5 groups of 30 each. Group A served as a control. Group B received 50 mg·kg1 of tranexamic acid at induction of anesthesia. Group C received 10 mg·kg1 at induction followed by an infusion of 1 mg·kg1·h1. Group D had 10 mg·kg1 at induction, 10 mg·kg1 on bypass, and 10 mg·kg1 after protamine. Group E had 20 mg·kg1 at induction and again after protamine. The control group had the longest sternal closure time, the greatest blood loss in the first 24 hours, and the highest requirements for blood and blood products. Among the 4 groups given tranexamic acid, group D (triple dose) had the best results, followed by group E (double dose). Group B (single dose) had the worst results among the groups receiving tranexamic acid.
This article has been cited by other articles:
![]() |
M. P. Eaton Antifibrinolytic Therapy in Surgery for Congenital Heart Disease Anesth. Analg., April 1, 2008; 106(4): 1087 - 1100. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |